SCHEMBL27085702

SCHEMBL27085702

CN(C)c1cccc(Nc2cc[nH]c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.47
EGFR P00533 2/20 0.39
ALDH1A1 P00352 4/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NTRK1 P04629 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.37
APP P05067 1/20 0.36
ACP1 P24666 2/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3030672 0.84 KDM1A (0.59) KDM1AEGFRALDH1A1TSHRMAPT
SCHEMBL28557487 0.78 KDM1A (0.63) KDM1AEGFRALDH1A1TSHRMAPT
SCHEMBL27085709 0.74 NEK2 (0.45)
SCHEMBL8842433 0.74 RAPGEF4 (0.46) EGFRALDH1A1MAPTMEN1KMT2A
SCHEMBL31652360 0.73 MEN1 (0.54) EGFRALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL3174911 0.73 HSD17B10 (0.33) ALDH1A1TSHRKMT2AALOX15MAPK1
SCHEMBL10571080 0.72 KDM1A (0.53) KDM1AEGFRALDH1A1TSHRMAPT
SCHEMBL9649012 0.72 ALDH1A1 (0.53) KDM1AEGFRALDH1A1TSHRMAPT
SCHEMBL3958554 0.72 HSD17B10 (0.57) ALDH1A1TSHRMAPTMEN1KMT2A
SCHEMBL1268756 0.70 ALDH1A1 (0.50) KDM1AEGFRALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11897883-B1 Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors King Faisal University (SA) 2024-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11897883-B1 Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors CSNK2A2, CSNK2A1, CSNK2A3 KDM1A 2963/4885EGFR 942/4885ALDH1A1 4008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.